Pharming Group N.V.: Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow

Full year 2025 total revenues increased by 27% to US$376.1 million, driven by continued growth of RUCONEST and rising demand for Joenja (leniolisib) Fourth quarter 2025 total revenues increased by 15% ...
Armed robbery in Revesby

Innovation Key to Jobs, Growth in Central, Eastern Europe

BRUSSELS, March 12, 2026-Bulgaria, Croatia, Poland, and Romania could raise labor productivity by up to 10 to 15 percent through wider adoption of digital technologies, particularly software and ...